OBJECTIVES: There are no studies of fatigue levels in patients with SSc. The objective of this study was to compare fatigue in SSc to general population samples and patients with rheumatic diseases and cancer, where fatigue has been researched extensively. METHODS: SSc patients completed the General Fatigue Index (GFI) of the Multidimensional Fatigue Inventory. A systematic review was conducted to select comparison samples. Mean GFI scores from SSc patients were compared with mean scores from comparison samples with t-tests and Bonferroni corrections (family-wise P < 0.05). RESULTS: A total of 106 SSc patients were sampled (97 females; 28 diffuse SSc; 11.9 +/- 7.9 yrs since diagnosis). Based on comparisons from the systematic review, mean GFI scores in SSc (13.3 +/- 4.6) were significantly higher (greater fatigue; P < 0.05) than in two large population samples (8.7 and 9.6) and than in two samples of cancer patients in remission (9.4 and 10.0). Scores for the SSc sample were significantly lower (less fatigue) compared with two samples of cancer patients in palliative care (16.8 and 17.0). SSc GFI scores were similar to scores from patients with RA (13.4), AS (13.0) and SLE (13.1) and to scores from six studies of cancer patients in active treatment (11.1-13.5). CONCLUSIONS: The high levels of fatigue reported in SSc were similar to patients with varying types and treatment stages of cancer and patients with other rheumatic diseases when assessed with the GFI, demonstrating that fatigue warrants greater attention in SSc.
OBJECTIVES: There are no studies of fatigue levels in patients with SSc. The objective of this study was to compare fatigue in SSc to general population samples and patients with rheumatic diseases and cancer, where fatigue has been researched extensively. METHODS: SSc patients completed the General Fatigue Index (GFI) of the Multidimensional Fatigue Inventory. A systematic review was conducted to select comparison samples. Mean GFI scores from SSc patients were compared with mean scores from comparison samples with t-tests and Bonferroni corrections (family-wise P < 0.05). RESULTS: A total of 106 SSc patients were sampled (97 females; 28 diffuse SSc; 11.9 +/- 7.9 yrs since diagnosis). Based on comparisons from the systematic review, mean GFI scores in SSc (13.3 +/- 4.6) were significantly higher (greater fatigue; P < 0.05) than in two large population samples (8.7 and 9.6) and than in two samples of cancerpatients in remission (9.4 and 10.0). Scores for the SSc sample were significantly lower (less fatigue) compared with two samples of cancerpatients in palliative care (16.8 and 17.0). SSc GFI scores were similar to scores from patients with RA (13.4), AS (13.0) and SLE (13.1) and to scores from six studies of cancerpatients in active treatment (11.1-13.5). CONCLUSIONS: The high levels of fatigue reported in SSc were similar to patients with varying types and treatment stages of cancer and patients with other rheumatic diseases when assessed with the GFI, demonstrating that fatigue warrants greater attention in SSc.
Authors: Ellen van Weert; Josette Hoekstra-Weebers; Renée Otter; Klaas Postema; Robbert Sanderman; Cees van der Schans Journal: Oncologist Date: 2006-02
Authors: Dinesh Khanna; Mansoor Ahmed; Daniel E Furst; Shaari S Ginsburg; Grace S Park; Richard Hornung; Joel Tsevat Journal: Arthritis Rheum Date: 2007-02-15
Authors: Lisa M Benrud-Larson; Jennifer A Haythornthwaite; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara White; Fredrick M Wigley Journal: Pain Date: 2002-02 Impact factor: 6.961
Authors: B Holzner; G Kemmler; R Greil; M Kopp; A Zeimet; M Raderer; M Hejna; S Zöchbauer; G Krajnik; H Huber; W W Fleischhacker; B Sperner-Unterweger Journal: Ann Oncol Date: 2002-06 Impact factor: 32.976
Authors: John W Williams; Michael Pignone; Gilbert Ramirez; Christina Perez Stellato Journal: Gen Hosp Psychiatry Date: 2002 Jul-Aug Impact factor: 3.238
Authors: D A Trojan; D Arnold; J-P Collet; S Shapiro; A Bar-Or; A Robinson; J-P Le Cruguel; T Ducruet; S Narayanan; K Arcelin; A N Wong; M C Tartaglia; Y Lapierre; Z Caramanos; D Da Costa Journal: Mult Scler Date: 2007-04-27 Impact factor: 6.312
Authors: Gianluca Bagnato; Francesca Cordova; Davide Sciortino; Giovanni Miceli; Antonio Bruno; Antonino Ferrera; Donatella Sangari; Giovanni Coppolino; Maria R A Muscatello; Gianluca Pandolfo; Rocco A Zoccali; William N Roberts Journal: Rheumatol Int Date: 2017-10-30 Impact factor: 2.631
Authors: Brett D Thombs; Lisa R Jewett; Shervin Assassi; Murray Baron; Susan J Bartlett; Angela Costa Maia; Ghassan El-Baalbaki; Daniel E Furst; Karen Gottesman; Jennifer A Haythornthwaite; Marie Hudson; Ann Impens; Annett Korner; Catarina Leite; Maureen D Mayes; Vanessa L Malcarne; Sarosh J Motivala; Luc Mouthon; Warren R Nielson; Diane Plante; Serge Poiraudeau; Janet L Poole; Janet Pope; Maureen Sauve; Russell J Steele; Maria E Suarez-Almazor; Suzanne Taillefer; Cornelia H van den Ende; Erin Arthurs; Marielle Bassel; Vanessa Delisle; Katherine Milette; Allison Leavens; Ilya Razykov; Dinesh Khanna Journal: Clin Exp Rheumatol Date: 2012-05-29 Impact factor: 4.473
Authors: Terry A McNearney; Sonya E Hunnicutt; Michael Fischbach; Alan W Friedman; Martha Aguilar; Chul W Ahn; John D Reveille; Jeffrey R Lisse; Bruce A Baethge; Niti Goel; Maureen D Mayes Journal: J Rheumatol Date: 2009-11-16 Impact factor: 4.666
Authors: Shervin Assassi; Astrud L Leyva; Maureen D Mayes; Roozbeh Sharif; Deepthi K Nair; Michael Fischbach; Ngan Nguyen; John D Reveille; Emilio B Gonzalez; Terry A McNearney Journal: PLoS One Date: 2011-10-14 Impact factor: 3.240